Freeline Therapeutics Holdings plc
Initiate clinical trial sites for the FLT180a dose confirmation trial
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 8 Feb 2021
- Due
- 31 Dec 2021
- Delivered
- December 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“initiating the clinical trial sites for the dose confirmation trial by the end of 2021”
What we found
Evidence strength A What the grades mean
The company confirmed in its filings that it met its objective to initiate at least one clinical trial site for the FLT180a B-LIEVE dose confirmation trial by the end of 2021.
-
A Freeline Therapeutics Holdings plc 20-F filed 2022-03-31
“We met our objective to initiate at least one clinical trial site for our Phase 1/2 B-LIEVE dose confirmation trial by the end of 2021” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- FLT180a dose confirmation trial sites
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Regulatory, Customer
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Freeline Therapeutics Holdings plc? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C810031-023224 · Corrections policy